Cargando…
Lung Cancer Survival with Current Therapies and New Targeted Treatments: A Comprehensive Update from the Srinagarind Hospital-Based Cancer Registry from (2013 to 2017)
BACKGROUND: Lung cancer (LC) is a common malignancy and leading cause of cancer death worldwide and in Thailand. An update on LC survival factors after diagnosis at Srinagarind Hospital is needed. METHODS: We conducted a retrospective cohort study, and the data were sourced from the Srinagarind Hosp...
Autores principales: | Musika, Wachiraporn, Kamsa-Ard, Supot, Jirapornkul, Chananya, Santong, Chalongpon, Phunmanee, Anakapong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629471/ https://www.ncbi.nlm.nih.gov/pubmed/34452564 http://dx.doi.org/10.31557/APJCP.2021.22.8.2501 |
Ejemplares similares
-
Outcomes of Treatment, Survival Rates, and Factors related to Survival of Stage III Lung Cancer Patients Treated at Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Thailand
por: Raksasri, Nattaporn, et al.
Publicado: (2023) -
Decreasing trends in cholangiocarcinoma incidence and relative survival in Khon Kaen, Thailand: An updated, inclusive, population-based cancer registry analysis for 1989–2018
por: Kamsa-ard, Supot, et al.
Publicado: (2021) -
Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study
por: Kamsa-ard, Supot, et al.
Publicado: (2019) -
Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study
por: Kamsa-ard, Supot, et al.
Publicado: (2020) -
Lack of Association between Red Meat Consumption and a Positive Fecal Immunochemical Colorectal Cancer Screening Test in Khon Kaen, Thailand: a Population- Based Randomized Controlled Trial
por: Pramual, Putthikrai, et al.
Publicado: (2018)